PMID: 2096381Nov 1, 1990Paper

5-Hydroxytryptamine receptor subtypes

Pharmacology & Toxicology
S J Peroutka

Abstract

Significant advances in the molecular pharmacological analysis of 5-hydroxytryptamine (5-HT) receptor subtypes occurred in the 1980's. To a significant degree, this progress resulted from 2 independent approaches: molecular biology and molecular pharmacology. This review focuses on the pharmacological data derived from radioligand binding studies. At the present time, 5-HT receptor subtypes are often categorized into at least 3 major "families" as well as a few "orphan" receptors that cannot yet be placed into the major categories. Each "family" consists of multiple receptor subtypes which share similarities in their molecular biological, pharmacological, biochemical and physiological properties. In order to provide a comparative pharmacological analysis of the 7 most extensively characterized 5-HT receptor subtypes, potency information is presented on the 30 pharmacological agents that have been, to date, studied most extensively in the published literature.

References

Mar 9, 1978·Nature·J E LeysenP M Laduron
Jun 21, 1990·European Journal of Pharmacology·G J KilpatrickA W Oxford
Apr 12, 1989·European Journal of Pharmacology·S J Peroutka, B G McCarthy
Jul 1, 1989·Naunyn-Schmiedeberg's Archives of Pharmacology·P Schoeffter, D Hoyer
Sep 1, 1989·British Journal of Pharmacology·M J Sumner, P P Humphrey
Oct 1, 1989·Differentiation; Research in Biological Diversity·M F PeraJ M Parrington
Feb 1, 1989·Trends in Pharmacological Sciences·P R Hartig
Apr 1, 1989·Trends in Pharmacological Sciences·D Hoyer, D N Middlemiss
Sep 1, 1989·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A W Schmidt, S J Peroutka
Oct 1, 1989·Trends in Pharmacological Sciences·D E ClarkeJ R Fozard
Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·S M MolineauxD Julius
Aug 1, 1988·British Journal of Pharmacology·P P HumphreyD Butina
Mar 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·D HoyerH Davies
Nov 10, 1987·European Journal of Pharmacology·T J WanderE Richelson
Aug 1, 1988·The Journal of Pharmacy and Pharmacology·N M BarnesF D Tattersall
Mar 18, 1986·European Journal of Pharmacology·R E HeuringS J Peroutka
Sep 28, 1987·Life Sciences·D L NelsonH I Yamamura
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·G M MaweM D Gershon
Oct 29, 1985·European Journal of Pharmacology·M TitelerR A Glennon
Jan 1, 1984·Journal of Neurochemistry·R G SchnellmannD L Nelson
Sep 1, 1957·British Journal of Pharmacology and Chemotherapy·J H GADDUM, Z P PICARELLI

❮ Previous
Next ❯

Citations

May 1, 1993·Medicinal Research Reviews·R M Pinder, J H Wieringa
Mar 1, 1997·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·L MastropasquaC Costagliola
Nov 20, 2010·Journal of Computer-aided Molecular Design·Maria Elena SilvaStefan Dove
Sep 4, 1992·European Journal of Pharmacology·M BodelssonB Arneklo-Nobin
Mar 30, 1993·European Journal of Pharmacology·M NoguchiS Chiba
Apr 1, 1994·Brain Research. Molecular Brain Research·M PompeianoG Mengod
Dec 1, 1994·Neurochemistry International·F Saudou, R Hen
Jul 11, 2002·European Journal of Pharmacology·Hans C DringenbergAlanna Bruce
Jun 1, 1995·Critical Care Medicine·J J FerraraL M Flint
Oct 1, 1994·Journal of Veterinary Pharmacology and Therapeutics·P BrikasL Bueno
Sep 1, 1991·Pharmacology & Toxicology·G Tunnicliff
Apr 16, 2004·Journal of Toxicology. Clinical Toxicology·Narendra GunjaAndis Graudins
Jul 1, 1993·Current Eye Research·N L Barnett, N N Osborne
Nov 1, 1992·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·C CrouzelV W Pike
Jul 1, 1997·Journal of Receptor and Signal Transduction Research·A FugelliG Fillion
Mar 9, 1999·General and Comparative Endocrinology·B A Chua, A M Perks
Mar 1, 1992·Visual Neuroscience·S C Mangel, W J Brunken
Apr 1, 1997·Journal of Clinical Psychopharmacology·P K Gillman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.